Magle PharmaCept is committed to bringing life changing healthcare innovations to patients.
We innovate based on Degradable Starch Microspheres (DSM) to develop groundbreaking medical devices in three clinical categories:
• Surgical
• Drug-delivery in oncological treatments
• Advanced wound care
Basing our solutions on this proprietary platform is more than just a choice of technology; it's a commitment to deliver safe and effective solutions that create value for patients across all the different therapeutic areas. The use of DSM technology is supported by robust evidence, and when combined with active ingredients, DSM can offer innovative solutions to healthcare needs in novel ways.
Company Details
- Employees
- 5
- Address
- 82 Bessemerstraße, Berlin,berlin 12103,germany
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pharmacept.com
- HQ
- Berlin, Berlin
Magle Pharmacept Questions
Magle Pharmacept's website is pharmacept.com
Magle Pharmacept's LinkedIn profile is https://de.linkedin.com/company/maglepharmacept
Magle Pharmacept has
5 employees.
View email and phone details for 5
employees at Magle Pharmacept.
Magle Pharmacept's industry is
Pharmaceutical Manufacturing
Magle Pharmacept's top competitors are
Rechon Life Science Ab,
Apl (Apotek Produktion & Laboratorier Ab),
Camurus,
Galenica Ab,
Magle Chemoswed,
Bioglan Ab,
Magle Biopolymers,
Magle Biopharma,
Sever Pharma Solutions,
Sirtex Medical Limited.
Magle Pharmacept's categories are Pharmaceutical Manufacturing
